Citation: | LI Yi, NI Weibo, CHI Yi, SHANG Huanxia, GUO Lijuan. The clinical value of NF-κB, IL-6, IL-10, IFN-α and T cell subsets in peripheral blood in predicting the prognosis of AECOPD patients[J]. Chinese Journal of General Practice, 2025, 23(4): 588-591. doi: 10.16766/j.cnki.issn.1674-4152.003957 |
[1] |
盖美华, 富燕萍, 金艾香, 等. 不同光照方式对重症AECOPD患者血清褪黑素及氧化应激水平的影响[J]. 中华全科医学, 2022, 20(10): 1662-1665. doi: 10.16766/j.cnki.issn.1674-4152.002673
GAI M H, FU Y P, JIN A X, et al. Influence on levels of melatonin and oxidative stress in critically ill patients with AECOPD treated by different ways of light[J]. Chin J Gen Pract, 2022, 20(10): 1662-1665. doi: 10.16766/j.cnki.issn.1674-4152.002673
|
[2] |
PRATT A J, PURSSELL A, ZHANG T, et al. Complexity in clinical diagnoses of acute exacerbation of chronic obstructive pulmonary disease[J]. BMC Pulm Med, 2023, 23(1): 298. DOI: 10.1186/s12890-023-02587-1.
|
[3] |
王静, 李英, 王贵佐. 慢性阻塞性肺疾病患者外周血单核细胞沉默信息调节因子2相关酶1 mRNA、核因子κB mRNA表达变化与病情及肺功能的相关性分析[J]. 中国医师进修杂志, 2024, 47(8): 765-768.
WANG J, LI Y, WANG G Z. Correlation analysis of mRNA expression of silence-message regulator 2 related enzyme 1 and nuclear factor κB in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease and lung function[J]. Chin J Postgrad Med, 2024, 47(8): 765-768.
|
[4] |
欧阳张宁, 高凌云. 白细胞介素与慢性阻塞性肺疾病急性加重期患者预后关系的研究进展[J]. 医学综述, 2023, 29(17): 3418-3423.
OUYANG Z N, GAO L Y. Research progress on the relationship between interleukin and prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Med Review, 2023, 29(17): 3418-3423.
|
[5] |
PONS M J, MAYANGA-HERRERA A, PALOMINO-KOBAYASHI L A, et al. High anti-interferon-alpha autoantibody levels in severe/critical COVID-19 patients from Peru[J]. J Interferon Cytokine Res, 2023, 43(12): 565-570. doi: 10.1089/jir.2023.0087
|
[6] |
赵萌. T淋巴细胞亚群在慢性阻塞性肺疾病发生、发展中的作用研究进展[J]. 检验医学与临床, 2023, 20(5): 705-709.
ZHAO M. Research progress on the role of T lymphocyte subsets in the occurrence and development of chronic obstructive pulmonary disease[J]. Lab Med Clin, 2023, 20(5): 705-709.
|
[7] |
高建荣, 叶亚兰, 高硕, 等. IL-6、PNI与老年慢性阻塞性肺疾病急性加重期患者预后的关系[J]. 皖南医学院学报, 2022, 41(2): 142-145.
GAO J R, YE Y L, GAO S, et al. IL-6 and prognostic nutritional index and the prognosis in elderly patients with chronic obstructive pulmonary disease in acute exacerbation stage[J]. Acta Acad Med Wannan, 2022, 41(2): 142-145.
|
[8] |
慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J]. 国际呼吸杂志, 2017, 37(14): 1041-1057.
Expert Group on Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD). Expert consensus on the diagnosis and treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in China (2017 update)[J]. Int J Resp, 2017, 37(14): 1041-1057.
|
[9] |
刘艳群, 王勤, 熊伟, 等. 住院慢性阻塞性肺疾病急性加重期患者合并低钠血症的相关危险因素分析[J]. 西部医学, 2024, 36(9): 1350-1354.
LIU Y Q, WANG Q, XIONG W, et al. A study on the risk factors for hyponatremia in hospitalized acute exacerbation of chronic obstructive pulmonary disease patients[J]. Med J West Chin, 2024, 36(9): 1350-1354.
|
[10] |
黄茂晟, 张红梅, 陆海燕, 等. CC-16及炎症因子水平用于AECOPD预后评估的价值研究[J]. 国际呼吸杂志, 2022, 42(2): 126-131.
HUANG M S, ZHANG H M, LU H Y, et al. Study on the prognostic value of CC-16 and inflammatory factors in acute exacerbation of chronic obstructive pulmonary disease[J]. Int J Resp, 2022, 42(2): 126-131.
|
[11] |
PANEK I, LICZEK M, GABRYELSKA A, et al. Inflammasome signalling pathway in the regulation of inflammation-its involvement in the development and exacerbation of asthma and chronic obstructive pulmonary disease[J]. Postepy Dermatol Alergol, 2023, 40(4): 487-495. http://openurl.ebsco.com/contentitem/doi:10.5114%2Fada.2022.118077?sid=ebsco:plink:crawler&id=ebsco:doi:10.5114%2Fada.2022.118077
|
[12] |
王晓林, 李静, 范志强, 等. 血清sTLT-1、SP-D、NF-κB水平在脓毒症急性肺损伤预后评估中的价值[J]. 西部医学, 2024, 36(12): 1781-1785.
WANG X L, LI J, FAN Z Q, et al. Evaluation value of serum sTLT-1, SP-D and NF-κB for prognosis of sepsis combined with acute lung injury[J]. Med J West Chin, 2024, 36(12): 1781-1785.
|
[13] |
郭立娟, 商焕霞, 张罗元, 等. AECOPD患者外周血NF-κB、IL-34、CCL18水平与预后的关系探讨[J]. 河北医科大学学报, 2023, 44(10): 1141-1145.
GUO L J, SHANG H X, ZHANG L Y, et al. Relationship between peripheral blood NF-κB, IL-34, CCL18 levels and prognosis in patients with AECOPD[J]. J Hebei Med Univ, 2023, 44(10): 1141-1145.
|
[14] |
袁怀军, 罗利. 血清IL-6、TNF-α、MMP-9对慢性阻塞性肺疾病急性加重期患者预后的诊断价值[J]. 贵州医药, 2024, 48(4): 614-616.
YUAN H J, LUO L. The diagnostic value of serum IL-6, TNF-α and MMP-9 in the prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Guizhou Med J, 2024, 48(4): 614-616.
|
[15] |
许腾, 郝立君, 刘红春, 等. GRED对慢性阻塞性肺疾病患者血清IL-10、TGF-β1、sPD-1和sPD-L1表达水平及临床表现的影响[J]. 河北医学, 2024, 30(4): 575-579.
XU T, HAO L J, LIU H C, et al. Effect of reflux disease on the expression levels and clinical manifestations of serum IL-10, TGF-β1, sPD-1, and sPD-L1 in patients with chronic obstructive pulmonary disease[J]. Hebei Med, 2024, 30(4): 575-579.
|
[16] |
于易琼, 丁震, 徐康, 等. 血清白介素-10与慢阻肺患者肺功能之间的关系[J]. 临床肺科杂志, 2023, 28(11): 1692-1696.
YU Y Q, DING Z, XU K, et al. Relationship between serum interleukin-10 and lung function in patients with chronic obstructive pulmonary disease[J]. J Clin Pulm Med, 2023, 28(11): 1692-1696.
|
[17] |
孔德昭, 王科雯, 罗文晔, 等. 慢性阻塞性肺疾病急性加重期诊疗指南评价与综合分析[J]. 中国中医基础医学杂志, 2023, 29(8): 1307-1317.
KONG D Z, WANG K W, LUO W Y, et al. Evaluation and comprehensive analysis of diagnostic and treatment guidelines for acute exacerbation of chronic obstructive pulmonary disease[J]. Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 2023, 29(8): 1307-1317.
|
[18] |
XIONG X F, ZHU M, WU H X, et al. Immunophenotype in acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study[J]. Respir Res, 2022, 23(1): 137. http://pubmed.ncbi.nlm.nih.gov/35643501/
|
[19] |
QUEIROZ M A F, BRITO W R D S, PEREIRA K A S, et al. Severe COVID-19 and long COVID are associated with high expression of STING, cGAS and IFN-α[J]. Sci Rep, 2024, 14(1): 4974. DOI: 10.1038/s41598-024-55696-0.
|
[20] |
唐文君, 曾珠, 孙增涛, 等. 外周血T淋巴细胞亚群变化对于慢阻肺患者急性加重期相对危险性的评价[J]. 临床肺科杂志, 2023, 28(10): 1511-1518.
TANG W J, ZENG Z, SUN Z T, et al. Evaluation of the relative risk of patients with AECOPD by T lymphocyte subsets changes in peripheral blood[J]. Journal of Clinical Pulmonary Medicine, 2023, 28(10): 1511-1518.
|
[21] |
陈建, 汪久龙, 徐裕丰. 慢性阻塞性肺疾病患者T淋巴细胞亚群变化及与病情程度的关系[J]. 河北医药, 2023, 45(7): 1057-1060.
CHEN J, WANG J L, XU Y F. Changes of T lymphocyte subsets in patients with chronic obstructive pulmonary disease and its correlations with the degree of disease[J]. Hebei Med J, 2023, 45(7): 1057-1060.
|